急性肾衰患者血浆中DD, tPA和PAI的改变及临床意义
肾功能衰竭,,肾功能衰竭,急性;D二聚体;组织型纤溶酶原激活物;纤溶酶原灭活剂,急性肾衰患者血浆中DD,tPA和PAI的改变及临床意义,0引言,1对象和方法,2结果,3讨论,【参考文献】
Clinical significance of changes of DD, tPA and PAI in acute renal failure patientsTENG Yan, XUE WuJun, ZHANG Yan, JIANG HongLi, XIANG HeLi
1Nephropathy Center, First Hospital, Xian Jiaotong University, 2Department of Blood Typing, Blood Center of Shaanxi Province, Xian 710061, China
【Abstract】 AIM: To investigate the clinical significance and the changes of coagulation and fibrinolysis function in acute renal failure patients. METHODS: The level of plasma DD and the activity of tissuetype plasminogen activator (tPA) and plasminogen activator inhibitor (PAI) were determined in 37 acute renal failure (ARF) patients while those of the healthy people were used as control. RESULTS: ① The plasma DD level and the PAI activity in ARF patients were obviously higher and the tPA activity was lower than those in control group(P<0.05). ②Significant difference of the above changes was also found in postrenal failure groups, prerenal and renal failure groups and between simple ARF patients and renal failure patients combined with multiple organ dysfunction syndrome (MODS)(P<0.05). CONCLUSION: There was a disorder of coagulation and fibrinolysis system in ARF patients. ARF, caused by ischemic and toxicosis or combined with MODS, has the greatest effect on the changes on coagulation system. Plasma DD, tPA and PAI can be used clinically as effective and sensitive markers reflecting the abnormal changes of coagulation and fibrinolysis system. ......
您现在查看是摘要页,全文长 9201 字符。